These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12796540)

  • 21. Reversal of intraoperative arterial thrombosis with a fibrinolytic agent when treating large and giant partially thrombosed aneurysms of the middle cerebral artery.
    Eliava S; Pilipenko Y; Shekhtman O; Konovalov A
    J Neurosurg; 2016 Apr; 124(4):1114-22. PubMed ID: 26430845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous and arterial thrombosis following administration of intravenous immunoglobulins.
    Paran D; Herishanu Y; Elkayam O; Shopin L; Ben-Ami R
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):313-8. PubMed ID: 15970713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolysis with recombinant tissue plasminogen activator in 7 children.
    Evim MS; Bostan Ö; Baytan B; Semizel E; Günes AM
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):574-7. PubMed ID: 22496087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial occlusions.
    Dawson KJ; Hamilton G
    Radiology; 1991 Jan; 178(1):283-4. PubMed ID: 1898537
    [No Abstract]   [Full Text] [Related]  

  • 25. Need for tissue plasminogen activator for central venous catheter dysfunction is significantly associated with thrombosis in pediatric cancer patients.
    MacLean J; MacDonald T; Digout C; Smith N; Rigby K; Kulkarni K
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27015. PubMed ID: 29537717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of significant resolution of cerebral sino-venous thrombosis associated with intravenous recombinant tissue plasminogen activator.
    Misra V; Elliott DG; Gonzalez-Toledo E; Kelley RE
    J Neuroimaging; 2007 Oct; 17(4):348-9. PubMed ID: 17894626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.
    Viegas LD; Stolz E; Canhão P; Ferro JM
    Cerebrovasc Dis; 2014; 37(1):43-50. PubMed ID: 24356180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue plasminogen activator in the treatment of superior vena caval thrombosis associated with parenteral nutrition.
    Barclay GR; Allen K; Pennington CR
    Postgrad Med J; 1990 May; 66(775):398-400. PubMed ID: 2115160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl.
    Golomb MR; Rafay M; Armstrong D; Massicotte P; Curtis R; Hune S; deVeber GA
    J Child Neurol; 2003 Jun; 18(6):420-3. PubMed ID: 12886978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Thrombus Length on Outcomes After Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial.
    Yoo AJ; Khatri P; Mocco J; Zaidat OO; Gupta R; Frei D; Lopes D; Shownkeen H; Berkhemer OA; Meyer D; Hak SS; Kuo SS; Buell H; Bose A; Sit SP; von Kummer R;
    Stroke; 2017 Jul; 48(7):1895-1900. PubMed ID: 28596447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter-Directed Low-Dose Tissue Plasminogen Activator for Treatment of Right Atrial Thrombus Caused by a Central Venous Catheter.
    Orgeron GM; Pollard JL; Pourmalek P; Sloane PJ
    Pharmacotherapy; 2015 Oct; 35(10):e153-8. PubMed ID: 26497485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral sinus thrombosis in a patient with humoral immunodeficiency on intravenous immunoglobulin therapy: a case report.
    Barada W; Muwakkit S; Hourani R; Bitar M; Mikati M
    Neuropediatrics; 2008 Apr; 39(2):131-3. PubMed ID: 18671192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Manco-Johnson MJ; Grabowski EF; Hellgreen M; Kemahli AS; Massicotte MP; Muntean W; Peters M; Schlegel N; Wang M; Nowak-Göttl U
    Thromb Haemost; 2002 Jul; 88(1):157-8. PubMed ID: 12152658
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacologic therapies in the treatment of peripheral vascular disease: clinical experience with reteplase, a third-generation thrombolytic.
    Laird JR
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():27B-32B. PubMed ID: 10731297
    [No Abstract]   [Full Text] [Related]  

  • 37. A simplified procedure for intra-arterial thrombolysis with tissue-type plasminogen activator in peripheral arterial occlusive disease: primary and long-term results.
    Decrinis M; Pilger E; Stark G; Lafer M; Obernosterer A; Lammer J
    Eur Heart J; 1993 Mar; 14(3):297-305. PubMed ID: 8458348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reteplase: a review of its use in the management of thrombotic occlusive disorders.
    Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
    Am J Cardiovasc Drugs; 2006; 6(4):265-85. PubMed ID: 16913828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombolysis with reteplase for recurrent mechanical heartvalve thrombosis.
    Akhtar N; Khan YJ; Ahmed W
    J Pak Med Assoc; 2011 Feb; 61(2):189-92. PubMed ID: 21375177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive cerebral venous thrombosis associated with moderate hyperhomocyst(e)inemia and successfully treated with thrombolysis.
    Chaves C; Voetsch B; Loscalzo J; Caplan L; Chavali R
    Cerebrovasc Dis; 2002; 13(3):214-6. PubMed ID: 11914541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.